STOCK TITAN

Dolby Executive's $1.85M Stock Sale Follows Recent $2.5M June Disposal

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Dolby Laboratories (DLB) insider filing reports planned sale of 25,000 shares of common stock with an aggregate market value of $1,850,530. The securities were acquired through a stock option exercise on June 24, 2025, and are planned to be sold through Morgan Stanley Smith Barney LLC on the NYSE.

The filing also discloses recent trading activity by the Yeaman Family Trust, which sold:

  • 25,000 shares for gross proceeds of $1,905,650 on June 10, 2025
  • 8,683 shares for gross proceeds of $661,829 on June 10, 2025

This Form 144 represents a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. The total shares to be sold represent approximately 0.026% of Dolby's outstanding shares (96,066,188 shares).

Positive

  • None.

Negative

  • Insider selling pattern: Multiple sales by the Yeaman Family Trust totaling 33,683 shares worth approximately $2.57M in June 2025, followed by another planned sale of 25,000 shares worth $1.85M
  • The aggregate insider sales within a short period (approximately $4.42M total) could signal reduced confidence in near-term stock performance

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many DLB shares are being sold according to the June 2025 Form 144 filing?

According to the Form 144 filing, 25,000 shares of DLB common stock are proposed to be sold through Morgan Stanley Smith Barney LLC at an aggregate market value of $1,850,530.00.

What was the recent trading activity by the Yeaman Family Trust for DLB stock?

The Yeaman Family Trust made two sales of DLB stock on June 10, 2025: one sale of 25,000 shares for gross proceeds of $1,905,650.00, and another sale of 8,683 shares for gross proceeds of $661,828.68.

How were the DLB shares acquired that are being sold in this Form 144?

The shares were acquired through a Stock Option Exercise from the issuer (Dolby Laboratories) on June 24, 2025, with payment made in cash on the same date for 25,000 shares.

What is the total number of outstanding DLB shares according to the Form 144?

According to the Form 144 filing, Dolby Laboratories (DLB) has 96,066,188 shares outstanding.

When is the approximate date of sale for the DLB shares in this Form 144?

The approximate date of sale for the DLB shares is indicated as June 24, 2025, to be executed on the NYSE (New York Stock Exchange).